Narrow search
Showing 1 - 10 of 8,395
Cover Image
Forecasting Market Share in the US Pharmaceutical Market
Regnier, Stephane - 2016
Drug development is costly so drug makers need accurate estimates of sales potential. However, sales forecasts are often unreliable. Our study is unique in combining a large sample of drug classes with data on entry order and promotional spending to estimate peak market share while controlling...
Persistent link: https://www.econbiz.de/10012994767
Cover Image
On the importance of Swiss patient data for pharmaceutical R&D in Switzerland
Bentele, Riccardo; Weder, Rolf - 2024
Real-world data (RWD) are an increasingly important input into the pharmaceutical R&D process as shown by countries like the USA or Finland. As the availability of and access to Swiss RWD is rather limited, the question arises whether this creates a burden for pharmaceutical R&D in Switzerland....
Persistent link: https://www.econbiz.de/10014512421
Cover Image
Valuation of Intangible Assets : Estimating Late-Stage Development Cost of Pharmaceutical R&D
Favato, Giampiero; Mills, Roger - 2014
Policy makers need reliable estimates of direct costs of pharmaceutical R&D, in order to contain health-care costs and at the same time maintain a supportive environment for investment in research. This paper evaluates the application of parametric estimating methods to the late stage clinical...
Persistent link: https://www.econbiz.de/10014224317
Cover Image
The Effects of Detailing on Prescribing Decisions Under Quality Uncertainty
Ching, Andrew T.; Ishihara, Masakazu - 2010
Motivated by recent empirical findings on the relationship between new clinical evidence and the effectiveness of detailing, this paper develops a new structural model of detailing and prescribing decisions under the environment where both manufacturers and physicians are uncertain about drug...
Persistent link: https://www.econbiz.de/10014048404
Cover Image
Pharmaceutical innovation and health outcomes : empirical evidence from Taiwan
Hsieh, Chee-Ruey; Lo, Kuang-ta Vance; Hong, Yichen; … - In: Pharmaceutical innovation : incentives, competition, …, (pp. 242-261). 2007
Persistent link: https://www.econbiz.de/10003499023
Cover Image
Productivity and heterogeneous knowledge : exploring the relationship in a sample of drug developers
Bottazzi, Giulio; Plotnikova, Tatiana - 2010
This paper aims to investigate the effect of knowledge characteristics on the total factor productivity of firms … coherence vs. market coherence and of accumulated knowledge on the productivity of firms differs. Productivity increases with … project knowledge, the diversity of the project portfolio positively affects productivity. -- total factor productivity …
Persistent link: https://www.econbiz.de/10003989032
Cover Image
The impact of public basic research on industrial innovation : evidence from the pharmaceutical industry
Toole, Andrew A. - 2011 - This version: March 2011
While most economists believe that public scientific research fuels industry innovation and economic growth, systematic evidence supporting this relationship is surprisingly limited. In a recent study, Acemoglu and Linn (2004) identified market size as a significant driver of drug innovation in...
Persistent link: https://www.econbiz.de/10009374417
Cover Image
The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France
Lichtenberg, Frank R. - 2014
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I examine the effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality rates of residents of Germany, using...
Persistent link: https://www.econbiz.de/10013069689
Cover Image
Patenting Medical Products
Wijesinghe, Prasadi - 2018
The new creations and innovations which are formulated in the minds of the human minds are recognized as a mode of an intangible property which, people can enjoy a specific set of rights over them. These are called 'intellectual property' as it is attached with the intellect of the people.There...
Persistent link: https://www.econbiz.de/10012924441
Cover Image
Longitudinal analysis of generic substitution
Dalen, Dag Morten; Locatelli Biey, Marilena; Strøm, Steinar - 2010
Using an extensive longitudinal dataset extracted from the Norwegian Prescription Database (NorPD) containing all prescriptions written in the period January 2004 to June 2007, we selected two particular drugs (chemical substances) used against cholesterol. The two brand-name products on the...
Persistent link: https://www.econbiz.de/10008697144